GELS Stock Price Chart
Daily OHLCV with technical indicators — pan, zoom, and customize your view
04
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance
Revenue, net income, margins and EPS trends
06
EPS$-0.722023-06-30 → 2025-06-30
Free Cash Flow$-6M2024-06-30 → 2025-06-30
Valuation & Ratios07–12
Valuation
P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
GELS
5Y avg
Peer Median
Verdict
P/E
-2.4
·
·
·
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability
Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
GELS
5Y avg
Peer Median
Verdict
ROA
-31.5%
·
·
·
ROE
-43.0%
·
·
·
Financial Health
Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
GELS
5Y avg
Peer Median
Verdict
Current Ratio
0.3
·
·
·
Quick Ratio
0.1
·
·
·
Interest Coverage
-2.9
·
·
·
Growth
Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Per Share Metrics
EPS, book value per share, cash flow per share, dividend per share
Metric
5Y trend
GELS
5Y avg
Peer Median
Verdict
EPS (Diluted)
$-0.725Y avg ≈$-0.53
≈$-0.53
·
·
Capital Efficiency
Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
15
Income Statement11
Metric
Trend
2025
2024
Cost of Revenue
$115.4K
·
Gross Profit
$50.2K
·
R&D Expense
$628.6K
$276.1K
Operating Income
$-5M
$-3M
Interest Expense
$2M
$599.5K
Pretax Income
$-7M
$-4M
Net Income
$-7M
$-4M
EPS (Basic)
$-0.72
$-0.44
EPS (Diluted)
$-0.72
$-0.44
Shares (Basic)
9,272,375
8,118,075
EBITDA
$-4M
$-2M
Balance Sheet10
Metric
Trend
2025
2024
Cash & Equivalents
$344.6K
$24.5K
Receivables
$459.7K
$183.0K
Current Assets
$2M
$303.2K
PP&E (Net)
$15.9K
$16.6K
Intangibles
$20M
$20M
Total Assets
$21M
$21M
Accounts Payable
$572.1K
$2M
Current Liabilities
$6M
$4M
Total Liabilities
$6M
$6M
Stockholders' Equity
$16M
$15M
Cash Flow7
Metric
Trend
2025
2024
D&A
$1M
$1M
Other Non-cash
$-99.1K
$1M
Operating Cash Flow
$-6M
$-1M
CapEx
$3.1K
$3.1K
Investing Cash Flow
$-736.8K
$-148.2K
Financing Cash Flow
$6M
$843.9K
Free Cash Flow
$-6M
$-1M
Profitability2
Metric
Trend
2025
2024
ROA
-31.5%
-16.4%
ROE
-43.0%
-21.0%
Liquidity & Solvency3
Metric
Trend
2025
2024
Current Ratio
0.3
0.1
Quick Ratio
0.1
0.1
Interest Coverage
-2.9
-4.9
Per Share1
Metric
Trend
2025
2024
EPS (TTM)
$-0.72
$-0.44
Valuation (TTM)3
Metric
Trend
2025
2024
Net Income TTM
$-7M
$-4M
P/E
-2.4
·
Earnings Yield
-41.6%
·
No quarterly filings for GELS
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
16
Metric
2025-06-30
2024-06-30
2023-06-30
Net Income
$-7M
$-4M
$-4M
Diluted EPS
$-0.72
$-0.44
$-0.44
Metric
2025-06-30
2024-06-30
2023-06-30
Current Ratio
0.3
0.1
·
Quick Ratio
0.1
0.1
·
Metric
2025-06-30
2024-06-30
2023-06-30
Free Cash Flow
$-6M
$-1M
·
Institutional owners (13F)
6 filers
· $60K total
· As of June 30, 2026
17
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders6
Value held$60K
New positions3
Exited positions2
Institutional activity — Q2 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
3 (0 vs prior Q)
2 (+1 vs prior Q)
0 (0 vs prior Q)
2 (+1 vs prior Q)
+48K
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.